ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.150
-0.050 (-1.56%)
Sep 18, 2026, 4:08 PM HKT

HKG:1541 Statistics

Total Valuation

HKG:1541 has a market cap or net worth of HKD 1.35 billion. The enterprise value is 665.26 million.

Market Cap1.35B
Enterprise Value 665.26M

Important Dates

The last earnings date was Wednesday, August 26, 2026.

Earnings Date Aug 26, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:1541 has 429.66 million shares outstanding. The number of shares has increased by 7.81% in one year.

Current Share Class 418.63M
Shares Outstanding 429.66M
Shares Change (YoY) +7.81%
Shares Change (QoQ) +3.31%
Owned by Insiders (%) 16.40%
Owned by Institutions (%) 1.01%
Float 277.08M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.95
PB Ratio 1.88
P/TBV Ratio 1.87
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.91
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.57.

Current Ratio 2.66
Quick Ratio 2.58
Debt / Equity 0.57
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -29.96

Financial Efficiency

Return on equity (ROE) is -40.11% and return on invested capital (ROIC) is -15.96%.

Return on Equity (ROE) -40.11%
Return on Assets (ROA) -14.74%
Return on Invested Capital (ROIC) -15.96%
Return on Capital Employed (ROCE) -32.30%
Weighted Average Cost of Capital (WACC) 4.56%
Revenue Per Employee 864,547
Profits Per Employee -1.35M
Employee Count197
Asset Turnover 0.16
Inventory Turnover 0.10

Taxes

In the past 12 months, HKG:1541 has paid 60,033 in taxes.

Income Tax 60,033
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -72.66% in the last 52 weeks. The beta is 0.22, so HKG:1541's price volatility has been lower than the market average.

Beta (5Y) 0.22
52-Week Price Change -72.66%
50-Day Moving Average 3.39
200-Day Moving Average 4.44
Relative Strength Index (RSI) 40.40
Average Volume (20 Days) 600,520

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1541 had revenue of HKD 170.32 million and -265.74 million in losses. Loss per share was -0.63.

Revenue170.32M
Gross Profit 169.03M
Operating Income -245.30M
Pretax Income -267.85M
Net Income -265.74M
EBITDA -235.79M
EBIT -245.30M
Loss Per Share -0.63
Full Income Statement

Balance Sheet

The company has 1.09 billion in cash and 407.69 million in debt, with a net cash position of 685.15 million or 1.59 per share.

Cash & Cash Equivalents 1.09B
Total Debt 407.69M
Net Cash 685.15M
Net Cash Per Share 1.59
Equity (Book Value) 719.61M
Book Value Per Share 1.68
Working Capital 714.74M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 9.64M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 99.25%, with operating and profit margins of -144.02% and -156.03%.

Gross Margin 99.25%
Operating Margin -144.02%
Pretax Margin -157.27%
Profit Margin -156.03%
EBITDA Margin -138.44%
EBIT Margin -144.02%
FCF Margin n/a

Dividends & Yields

HKG:1541 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -7.81%
Shareholder Yield -7.81%
Earnings Yield -19.63%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1